TIGERTRIEVER (TM) 13 is the first device shown to meet safety and effectiveness endpoints for restoring blood flow in smaller but critical areas of the brain, accounting for almost 50% of all ischemic ...
It’s a known problem, but treatment hasn’t improved in 20 years. Experts say it’s time for protocolized systems of care, they ...
New study reveals a central role of selenoprotein GPX3 in attenuating acute kidney injury Renal ischemia–reperfusion injury ...
Please provide your email address to receive an email when new articles are posted on . Among patients who required interhospital transfer for STEMI, nearly 40% had cath lab activation times of less ...
MedPage Today on MSN
Stroke trial tips scale further to favor intra-arterial lytic after EVT
CHOICE-2 supports intra-arterial alteplase after successful reperfusion ...
Alternative model systems to study ischemia-reperfusion are needed to support a wide range of disease-related investigations in the life sciences. Ischemia and reperfusion are relevant to many disease ...
Acute ST-segment elevation myocardial infarction is estimated to occur in more than 500,000 people in the US every year. With the introduction of reperfusion therapy by fibrinolysis or primary ...
Under ischemic conditions, the deficiency of oxygenated blood supply to the myocardium makes the energy requirements of the heart impossible to satisfy. Several metabolic alterations derive from ...
Rapid Medical announces DISTALS trial results showing TIGERTRIEVER 13 achieved superior brain reperfusion with strong safety in MVO ischemic stroke.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results